Brains Bioceutical Achieves CEP Certification for Pharmaceutical-Grade Cannabidiol

CEP certification confirms Brains Bio’s naturally-derived CBD pharmaceutical ingredient meets European Pharmacopoeia standards, providing a significant regulatory advantage for drug developers and strengthening the Company’s position across EU and Ph. Eur.-aligned markets worldwide.